7:00-7:55 a.m. Continental Breakfast, Exhibits, Posters

7:55 a.m. Welcome & Opening Remarks
Donald R. Westerhausen, Jr., MD, FACC

8:00-8:45 a.m.  What Is Impacting CV Clinicians in 2019 – Report from the ACC
Richard J. Kovacs, MD, FACC, ACC President & Mary Norine Walsh, MD, MACC, ACC Past President

8:45-9:30 a.m. Putting It Into Practice: A Review of Cardiovascular Outcome Trials with Diabetes Therapies
Woodrow A. Corey, MD, FACC and Stacey Harris, RN, CDE
handout

9:30-10:00 a.m. FIT Oral Competition
> Left atrial hypertension and the risk of recurrent heart failure after atrial fibrillation ablation – Jasen Gilge, MD  abstract
> Multi-View Right Ventricular Strain is a Better Predictor of Cardiovascular Events Compared with Right Ventricular Free Wall Longitudinal Strain – Upasana Jarori, MD  abstract

10:00-10:15 a.m. Pearls from the Teaching Tomorrow’s Teachers Program
Kavita Khaira, MD
handout

10:15-10:45 a.m. Break, Exhibit, Posters

10:45-11:30 a.m. Personalized Medicine
Katherine G. Spoonamore, MS
handout

11:30 a.m. – 12:15 p.m. High Performing Work Teams: Enhancing Patient Outcomes and Professional Well-Being
Joel Sauer, MBA
handout

12:15-1:00 p.m. Break, Exhibits, Networking for Women Cardiologists & Networking for CV Team (RN, APN, Pharmacist, PA)

1:00-2:00 p.m. What’s New in Heart Failure: From Drugs to Devices
Kathleen Morris, DO and Vijay U. Rao, MD, PhD, FACC
Morris handout  |  Rao handout

2:00 p.m. Announcement of Poster Winners and Oral Competition Winners

Accreditation

Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Cardiology Foundation and Indiana Chapter of the American College of Cardiology. The American College of Cardiology Foundation is accredited by the ACCME to provide continuing medical education for physicians.

The ACCF designates this live educational activity for a maximum of 4.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurses
American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The ACCF designates this live educational activity for a maximum of 4.75 continuing education hours. Each attendee should only claim credits commensurate with the extent of their participation in the activity.

While offering credits noted above, the course is not intended to provide extensive training or certification in this field.

Statement of Need
While cardiovascular care is rapidly evolving due to new technologies and treatment options, healthcare providers need to be aware of the new heath care environment in which they practice as well as knowledge of the past advances and technologies which contributed to the current standards of optimal cardiovascular care. Healthcare providers need periodic educational updates on emerging clinical trials and advances in patient management to provide optimal care. Knowledge and competencies learned from case scenarios applicable to daily practice and changes to practice guidelines, will allow them to apply evidence-based research to their patient management decisions.

Overall Goal
The overall goal of this activity is to increase learner competence by discovering strategies to anticipate research-driven changes in practice, to enhance professional growth, and to demonstrate efficacy in patient care practice as new clinical approaches and technologies change. The Indiana Chapter-ACC Annual Meeting will include education that provides needs-based learning covering a thorough overview of health care legislation and regulations, cardiovascular outcome trials with diabetes therapies, speaking, presentation, and feedback skills for clinical presentations, personalized medicine, high performing working teams & provider wellness, and heart failure.

Learner Objectives
Upon completion of this program, participants should be able to:

• Implement tools, resources, and regulations that impact the cardiovascular business practice environment necessary to remain financially successful in an era of payment reform.
• Identify appropriate patients with type 2 diabetes mellitus as candidates to receive aspirin, ACE-I/ARB therapy, and statins for both primary and secondary prevention of cardiovascular events.
• Develop public speaking, presentation, and feedback skills for clinical presentations.
• Analyze how Personalized Medicine will change the way cardiovascular practitioners practice medicine in the future.
• Apply principles of effective team-based care to improve workforce wellness and patient outcomes.
• Employ latest advancements in the management of the heart failure patient.

Target Audience
Adult Cardiologists, Pediatric Cardiologists, Cardiothoracic Surgeons, Cardiology Fellows-in-Training, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Pharmacists

ACCF Disclosure & COI Policy Statement
ACCF/Chapter committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all real or apparent conflicts of interest. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, patient care and safety recommendations. Full disclosure will be published in the syllabus.

Appreciation is expressed to the following company for providing an educational grant:
AstraZeneca

Appreciation is expressed to the following companies for exhibiting at this conference:

GOLD SPONSOR – Medtronic

SILVER SPONSORS: Amgen, Edwards Lifesciences; Janssen, Johnson & Johnson Healthcare; Siemens Healthineers

Exhibitors:

Akcea Therapeutics, Inc.
American Heart Association
Amgen
Astellas Pharma US
AstraZeneca Pharmaceuticals (3)
Bayer Pharmaceuticals
Boehringer-Ingelheim
Boston Scientific
Cincinnati Children’s Hospital Medical Center
Edwards Lifesciences
iRhythm Technologies
Janssen Pharmaceuticals
Lantheus Medical Imaging
Medi-Lynx
Medtronic
Mercyhealth
Novartis
Penumbra Inc.
Pfizer
Pfizer Rare Disease
Privis Health
Regeneron
Siemens Healthineers
ZOLL LifeVest